Natasha Girgis
Seminars
Thursday 26th March 2026
A Novel Therapeutic Approach to Induce and Expand Tregs to Restore Immune Balance
2:30 pm
Key Discussion Points:
- Innovative engineering of CUE-401 enables dual agonism of IL-2 and TGF-β for the induction of regulatory T cells
- First-in-class CUE-401 mechanism is differentiated from other classes of Treg-directed therapies
- Translational studies support broad therapeutic opportunities across diverse indications
